INTRODUCTION
we analyzed whether transplantation of nonparencymal cells highly enriched with CK-19-positive biliary cells Adult rat hepatocytes that are transplanted into the resulted in an increased appearance of CK-19-positive spleen of syngeneic rats survive and function over a long cells in the spleen. The second possibility was examined period of time, indicating that transplantation of hepatoby analyzing whether transplantation of hepatocyte fraccytes into the spleen is a therapeutic option for the treattions depleted of precursors of oval cells resulted in dement of acute or chronic liver failure and congenital liver creased formation of CK-19-positive cells in the spleen metabolic disorders (5, 12, (17) (18) (19) . It has been shown that or, conversely, that of nonparenchymal cell fractions enhepatocyte transplantation into the spleen is accompariched with oval cells caused increased generation of CKnied by an appearance of biliary cells that form ductular 19-positive cells in the spleen. We show that neither structures (6, 9, 21) . However, the origin of these cells is biliary cells nor precursors of oval cells constitute the controversial, and several possibilities have been proorigin of biliary cells in the spleen and suggest that these posed (6, 21) . First, a few biliary cells contaminating hecells are generated through transdifferentiation of hepapatocyte preparations transplanted may proliferate to form tocytes transplanted into the spleen. ductular cells in the spleen. Second, precursors of oval cells (1, 22, 26) present in hepatocyte preparations may MATERIALS AND METHODS proliferate and differentiate into biliary cells. In this Chemicals study, we examined the first possibility by determining the proliferative activity of biliary cells that appeared in Sodium carboxymethylcellulose, 2-acetylaminofluorene the spleen after hepatocyte transplantation. In addition, (AAF), 4,4′-diaminodiphenylmethane (DAPM, 4,4′-meth- 28 FUKUDA ET AL. ylenedianiline), and collagenase were purchased from HBSS and centrifugation at 50 × g for 1 min. Precipitated hepatocytes were then suspended in Ca 2+ -and Wako Pure Chemical Industries (Osaka, Japan); protease E (actinase E) was from Kaken Pharmaceutical Co.
Mg 2+ -free 0.01 M phosphate-buffered saline (PBS), pH 7.4, and used for transplantation into the spleen. To iso-(Tokyo, Japan); and DNase I (from bovine pancreas), insulin (from bovine pancreas), hyaluronidase (Type I-late nonparenchymal cells, the supernatant was centrifuged at 50 × g for 1 min three times, and the final S, from bovine testes), and dexamethasone were from Sigma-Aldrich (St. Louis, MO).
supernatant was centrifuged at 50 × g for 5 min. Precipitated nonparenchymal cells were suspended in Ca 2+ -and Rats Mg 2+ -free PBS and used for transplantation into the Male Fisher 344 rats were purchased from Japan SLC spleen. Cell viability was determined by the trypan blue (Hamamatsu, Shizuoka, Japan). Rats were kept at 25°C exclusion test. under controlled light conditions (12 h light/12 h dark-Induction of Oval Cells [AAF/Partial Hepatectomy ness) and allowed free access to water and a pellet diet.
(PH) Model] All surgical procedures were performed under anesthesia with an intramuscular injection of 1.6 mg xylazine Treatment with AAF and PH was used to induce oval cell formation in the liver (3, 8, 13) . AAF was dissolved and 0.16 mg ketamine hydrochloride in 0.4 ml of saline. All experiments involving rats were approved by the in dimethyl sulfoxide at a concentration of 75 mg/ml and suspended in 1% sodium carboxymethyl cellulose Animal Care Committee of Hyogo College of Medicine, and the rats were given humane care.
in saline at a concentration of 1.5 mg/ml. Seven-weekold rats were administered AAF by gavage at a dose of Treatment of Rats With DAPM 10 mg/kg body weight daily for 4 days, and were subjected to two thirds PH on day 5. On day 6, the daily DAPM was dissolved in 100% ethanol and diluted to 40 mg/ml 40% ethanol with warmed distilled water (40°C) administration of AAF was resumed, and continued for 5 days, and on day 12 the liver was perfused for the (10) . Eight-week-old rats were administered DAPM by gavage at a dose of 300 mg/kg body weight, and 24 h isolation of liver cells. later the liver was perfused and removed to isolate liver Induction of Bile Duct Hyperplasia [Bile Duct cells as described below.
Ligation(BDL)/Furan Model] Isolation of Hepatocytes and Nonparenchymal Cells
Bile duct hyperplasia was induced by BDL followed From Livers of Normal Rats and DAPM-Treated Rats by administration of Furan (23). Seven-week-old rats were first subjected to BDL by double ligating the com-Liver cells were isolated using a collagenase digestion mon bile duct and then resecting the intervening segmethod with a slight modification (2, 19) . After cannulament. One week later, the rats were given Furan in corn tion of the portal vein, the inferior vena cava in the aboil by gavage at 36 mg/kg body weight daily for the first domen was ligated and that in the thoracic cavity was 5 days of the week. The 5-day administration of Furan cut, and the liver was perfused in situ with approxiwas continued for 3 additional weeks. Two days after mately 250 ml of Ca 2+ -and Mg 2+ -free Hanks' balanced the last administration, liver cells were isolated as desalt solution (HBSS), pH 7.4, at 37°C, and then with scribed below. 150 ml of HBSS containing 0.05% collagenase and 5 mM CaCl 2 at 37°C. During perfusion, the cut end of the
Isolation of Nonparenchymal Cells From Livers of Rats inferior vena cava was clamped occasionally to dilate
Treated With AAF/PH or BDL/Furan intrahepatic blood vessels. After perfusion, the liver was
The procedure was the same as that described above removed, the capsule was removed from the liver, and for the isolation of nonparenchymal cells from normal then the liver was minced with a razor blade. After rerats, except that the minced liver tissue was incubated in moval of fibrous tissues, the minced liver tissue was in-HBSS containing 0.1% collagenase, 5 mM CaCl 2 , 0.1% cubated in HBSS containing 0.05% collagenase and 5 protease E, 0.01% DNase I, 10 −4 M insulin, 10 −3 M dexa-mM CaCl 2 at 37°C for 10 min with gentle pipettings methasone, and 0.05% hyaluronidase at 37°C for 40 min several times. The treated liver preparation was filtered with vigorous pipettings several times (24,28). Cell viathrough 100 µm nylon mesh and centrifuged at 225 × g bility was determined by the trypan blue exclusion test. for 10 min. The liver cells precipitated were suspended in HBSS and centrifuged at 50 × g for 1 min. The pre-Transplantation of Hepatocytes or Nonparenchymal cipitated cell fraction and the supernatant were used to Cells Into the Spleen isolate hepatocytes and nonparenchymal cells, respectively. For the preparation of hepatocytes, precipitated Viable cells (1 × 10 7 ) were suspended in 0.3 ml of Ca 2+ -and Mg 2+ -free PBS and injected directly into the cells were subjected to two cycles of suspension in spleen of an 8-week-old syngeneic rat with hilar vessels A shrunken cell with condensed nuclei with or without fragmentation was regarded as an apoptotic cell (11,27). of the spleen clamped, and then the left branch of the portal vein was ligated.
Statistical Analysis Immunohistochemistry for Data are presented as mean ± SE. Bonferroni multiple comparison test was used to compare data from mul-Spleen and liver tissues were fixed in methacarn tiple groups. A value of p < 0.05 was considered signifi-(methanol/chloroform/glacial acetic acid, 6:3:1) for 2 h, cant. embedded in paraffin, and sectioned at a thickness of 5 µm. Immunohistochemistry of tissue sections for CK-RESULTS 19 was carried out as described previously using mouse Immunohistochemical analysis of hepatocytes used for monoclonal anti-human CK-19 IgG (1:10 dilution) (Amtransplantation showed that PAS-positive cells representersham International, Little Chalfont, Buckinghamshire, ing hepatocytes were 92.0% and CK-19-positive cells UK) (14).
representing biliary cells were 1.3% (Fig. 1 ). Time course To determine the number of CK-19-positive cells in analysis of PAS-and CK-19-positive cells after transthe spleen after transplantation of hepatocytes or nonpaplantation into the spleen showed that the number of renchymal cells, CK-19-positive cells were analyzed us-PAS-positive cells decreased rapidly for the first 4 weeks, ing two spleen sections cut through the largest diameter and then remained essentially unchanged ( Fig. 2 ). On and their numbers were averaged.
the other hand, the number of CK-19-positive cells was For determination of percentages of CK-19-positive low for the first week, increased rapidly, reaching the cells in liver cells prepared for transplantation, cells were maximum 4 weeks after transplantation, and then dedeposited onto glass slides by centrifugation at 1000 creased gradually. In the spleen, PAS-positive cells were rpm for 5 min in a Cytospin 3 cytocentrifuge (Shandon, clustered (Fig. 3A) , and CK-19-positive cells were local-Pittsburgh, PA), dried in cold air, fixed in methanol for ized in the biliary ductular structure (Fig. 3B ). 30 min, and kept in 95% ethanol overnight. The cells
To examine whether biliary ductular cells in the were then stained for CK-19 in the same manner as despleen transplanted with hepatocytes undergo proliferascribed above for immunohistochemistry and the numtion and/or apoptosis after hepatocyte transplantation, ber of CK-19-positive cells was counted.
we analyzed Ki-67 expression and apoptosis in these Immunohistochemistry of Ki-67 cells (Fig. 4) . The results showed that both Ki-67 labeling and apoptotic indices were low for 16 weeks after Immunohistochemistry of spleen sections for Ki-67 transplantation (Fig. 5 ), indicating no active proliferawas done using rabbit polyclonal anti-human Ki-67 antition or apoptosis in biliary ductular cells following hepabody (1:100 dilution) (Dako Japan, Kyoto, Japan) in the tocyte transplantation. same manner as for immunohistochemistry for CK- 19 To examine whether biliary cells contaminating transexcept that after deparaffinization, tissue sections were planted hepatocytes are the source of biliary cells in the immersed in 10% formalin in PBS for 1 h and subsequently heated in 0.01 M sodium citrate buffer, pH 6.0, at 121°C for 5 min in an autoclave BS325 (Tomy Seiko, Tokyo, Japan). A Ki-67 labeling index of biliary ductular cells was determined by examining more than 500 cells.
PAS Stain
To determine the number of PAS-positive cells in the spleen, two spleen sections cut through the largest diameter were stained for PAS and the numbers of PAS-positive cells were averaged.
For determination of PAS-positive cells in liver cells used for transplantation, cells were deposited on glass slides, treated in the same manner as for immunohistochemistry for CK-19, and stained for PAS. spleen after transplantation of hepatocytes, we performed transplantation experiments using nonparenchymal cells that contained a higher percentage (23.9%) of CK-19positive cells than hepatocytes (1.3%). In addition, we used nonparenchymal cell preparations in which CK-19positive cells were increased to 63.5% by treatment with BDR/Furan, which induces bile duct hyperplasia (Fig.  6 ). The percentage of PAS-positive cells in the nonparenchymal cell preparations was low (1.5%) with BDR/ planted hepatocyte preparations are the source of biliary cells in the spleen, we treated rats with DAPM to deplete precursors of oval cells as well as epithelial cells of bile DISCUSSION ducts (10,20) (Fig. 7) , prepared hepatocytes, and transplanted into the spleen. We found the appearance of nu-In this study, we attempted to determine the origin of CK-19-positive biliary ductular cells that are generated merous CK-19-positive biliary cells in the spleen ( Table  1 ), suggesting that precursors of oval cells were not the in the spleen of rats transplanted with hepatocytes. Our time course analysis showed that CK-19-positive cells origin of biliary ductular cells in the spleen. To confirm these results, we performed reciprocal experiments in which in the spleen increased rapidly in number for the first 4 weeks after hepatocyte transplantation, but the Ki-67 rats were treated with AAF/PH to induce oval cells in the liver (Fig. 6) , enriching the nonparenchymal cell frac-labeling index (7) was low. These results indicated that the increase in the number of CK-19-positive cells in tion with CK-19-positive oval cells. Transplantation of the oval cell-enriched nonparenchymal cell preparation the spleen was not due to proliferation of CK-19-positive biliary cells contained in transplanted hepatocytes. did not result in enhanced formation of CK-19-positive biliary cells in the spleen ( Table 1 ), suggesting that oval
In addition, transplantation of nonparenchymal cells enriched with CK-19-positive biliary cells from livers of cells were not the origin of biliary cells in the spleen. normal rats or rats with bile duct hyperplasia induced by the treatment with BDL/Furan did not result in the appearance of CK-19-positive cells in the spleen. These results show that biliary ductular cells in the spleen were not derived from CK-19-positive biliary cells in the liver. Original magnification ×40. (6) Nonparenchymal cells prepared from livers of normal, BDR/Furan-treated, and AAF/PH-treated rats, and hepatocytes prepared from DAPM-treated rats were transplanted into the spleen of syngeneic rats (1 × planted, it is tempting to speculate that these cells are the origin of CK-19-positive cells in the spleen. Consistent with this possibility, it has been reported that hepatocytes undergo phenotypic transformation to CK-19positive biliary cells in vitro (4, 15) . In particular, small hepatocytes have been shown to have a high proliferative capacity and differentiate into CK-19-positive biliary cells as well as hepatocytes in vitro (16, 25) . This suggests that, in the present experiments, small hepatocytes present in mature hepatocyte preparations used in transplantation may be the source of CK-19-positive cells in the spleen. However, this possibility was ruled out because we detected no CK-19-positive cells in the spleen after transplantation of nonparenchymal cells, which contain more small hepatocytes than hepatocytes transplanted (16, 25) . Therefore, it is conceivable that mature ( Fig. 2) . Decreases in the number of CK-19-positive cells in the spleen thereafter with no significant changes in an apoptotic index suggest that transdifferentiation of hepatocytes into CK-19-positive cells is a relatively Petersen et al. (20) have shown that biliary ductular early event following transplantation of hepatocytes into damages induced by DAPM inhibit the formation of the spleen. oval cells in the liver, indicating that DAPM also dam-Michalopoulos et al. (15) have recently shown that, ages precursors of oval cells assumed to be in contact in organoid culture of hybrid liver cells consisting of with biliary cells. However, transplantation of hepatodipeptidyl peptidase IV (DPPIV)-positive and -negative cytes depleted of precursors of oval cells from DAPMhepatocytes and DPPIV-negative bile ductular cells, treated rats did not affect the formation of CK-19-posi-DDPIV-positive biliary epithelial cells appeared on the tive biliary ductular cells in the spleen. In addition, no surface of the organoid whereas hepatocytes resided in-CK-19-positive cells were found in the spleen after transside. This suggests that transdifferentiation of hepatocytes plantation of nonparencymal cells enriched with oval into biliary cells may occur in vivo depending on the microcells induced by the treatment with AAF/PH. These reenvironment. Our results are consistent with this possisults suggest that oval cells were not the source of CKbility, showing that hepatocytes undergo phenotypic 19-positive cells in the spleen.
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